345 related articles for article (PubMed ID: 23428899)
21. Isolation and Characterization of an HLA-DRB1*04-Restricted HPV16-E7 T Cell Receptor for Cancer Immunotherapy.
Mercier-Letondal P; Marton C; Deschamps M; Ferrand C; Vauchy C; Chenut C; Baguet A; Adotévi O; Borg C; Galaine J; Godet Y
Hum Gene Ther; 2018 Oct; 29(10):1202-1212. PubMed ID: 30136612
[TBL] [Abstract][Full Text] [Related]
22. Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition.
Yang S; Cohen CJ; Peng PD; Zhao Y; Cassard L; Yu Z; Zheng Z; Jones S; Restifo NP; Rosenberg SA; Morgan RA
Gene Ther; 2008 Nov; 15(21):1411-23. PubMed ID: 18496571
[TBL] [Abstract][Full Text] [Related]
23. Generation of β cell-specific human cytotoxic T cells by lentiviral transduction and their survival in immunodeficient human leucocyte antigen-transgenic mice.
Babad J; Mukherjee G; Follenzi A; Ali R; Roep BO; Shultz LD; Santamaria P; Yang OO; Goldstein H; Greiner DL; DiLorenzo TP
Clin Exp Immunol; 2015 Mar; 179(3):398-413. PubMed ID: 25302633
[TBL] [Abstract][Full Text] [Related]
24. Human CD8(+) T cells transduced with an additional receptor bispecific for both Mycobacterium tuberculosis and HIV-1 recognize both epitopes.
Zhou CY; Wen Q; Chen XJ; Wang RN; He WT; Zhang SM; Du XL; Ma L
J Cell Mol Med; 2016 Oct; 20(10):1984-98. PubMed ID: 27113787
[TBL] [Abstract][Full Text] [Related]
25. A simplified method for the clinical-scale generation of central memory-like CD8+ T cells after transduction with lentiviral vectors encoding antitumor antigen T-cell receptors.
Yang S; Dudley ME; Rosenberg SA; Morgan RA
J Immunother; 2010; 33(6):648-58. PubMed ID: 20551831
[TBL] [Abstract][Full Text] [Related]
26. Design of T-cell receptor libraries with diverse binding properties to examine adoptive T-cell responses.
Chervin AS; Stone JD; Soto CM; Engels B; Schreiber H; Roy EJ; Kranz DM
Gene Ther; 2013 Jun; 20(6):634-44. PubMed ID: 23052828
[TBL] [Abstract][Full Text] [Related]
27. T-cell receptor gene transfer exclusively to human CD8(+) cells enhances tumor cell killing.
Zhou Q; Schneider IC; Edes I; Honegger A; Bach P; Schönfeld K; Schambach A; Wels WS; Kneissl S; Uckert W; Buchholz CJ
Blood; 2012 Nov; 120(22):4334-42. PubMed ID: 22898597
[TBL] [Abstract][Full Text] [Related]
28. Preclinical development of T-cell receptor-engineered T-cell therapy targeting the 5T4 tumor antigen on renal cell carcinoma.
Xu Y; Morales AJ; Cargill MJ; Towlerton AMH; Coffey DG; Warren EH; Tykodi SS
Cancer Immunol Immunother; 2019 Dec; 68(12):1979-1993. PubMed ID: 31686124
[TBL] [Abstract][Full Text] [Related]
29. Adoptive immunotherapy of disseminated leukemia with TCR-transduced, CD8+ T cells expressing a known endogenous TCR.
Dossett ML; Teague RM; Schmitt TM; Tan X; Cooper LJ; Pinzon C; Greenberg PD
Mol Ther; 2009 Apr; 17(4):742-9. PubMed ID: 19209146
[TBL] [Abstract][Full Text] [Related]
30. T Cell Receptor Engineered Lymphocytes for Cancer Therapy.
Rollins MR; Spartz EJ; Stromnes IM
Curr Protoc Immunol; 2020 Jun; 129(1):e97. PubMed ID: 32432843
[TBL] [Abstract][Full Text] [Related]
31. A novel Epstein-Barr virus-latent membrane protein-1-specific T-cell receptor for TCR gene therapy.
Cho HI; Kim UH; Shin AR; Won JN; Lee HJ; Sohn HJ; Kim TG
Br J Cancer; 2018 Feb; 118(4):534-545. PubMed ID: 29360818
[TBL] [Abstract][Full Text] [Related]
32. A rare population of tumor antigen-specific CD4
Matsuzaki J; Tsuji T; Chodon T; Ryan C; Koya RC; Odunsi K
J Immunother Cancer; 2019 Jan; 7(1):7. PubMed ID: 30626427
[TBL] [Abstract][Full Text] [Related]
33. Engineered cytotoxic T lymphocytes with AFP-specific TCR gene for adoptive immunotherapy in hepatocellular carcinoma.
Sun L; Guo H; Jiang R; Lu L; Liu T; He X
Tumour Biol; 2016 Jan; 37(1):799-806. PubMed ID: 26250457
[TBL] [Abstract][Full Text] [Related]
34. Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy.
Tsuji T; Yoneda A; Matsuzaki J; Miliotto A; Ryan C; Koya RC; Odunsi K
Cancer Immunol Res; 2018 May; 6(5):594-604. PubMed ID: 29588318
[TBL] [Abstract][Full Text] [Related]
35. Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety.
Ochi T; Fujiwara H; Okamoto S; An J; Nagai K; Shirakata T; Mineno J; Kuzushima K; Shiku H; Yasukawa M
Blood; 2011 Aug; 118(6):1495-503. PubMed ID: 21673345
[TBL] [Abstract][Full Text] [Related]
36. Generation of human islet-specific regulatory T cells by TCR gene transfer.
Hull CM; Nickolay LE; Estorninho M; Richardson MW; Riley JL; Peakman M; Maher J; Tree TI
J Autoimmun; 2017 May; 79():63-73. PubMed ID: 28117148
[TBL] [Abstract][Full Text] [Related]
37. RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma.
Harrer DC; Simon B; Fujii SI; Shimizu K; Uslu U; Schuler G; Gerer KF; Hoyer S; Dörrie J; Schaft N
BMC Cancer; 2017 Aug; 17(1):551. PubMed ID: 28818060
[TBL] [Abstract][Full Text] [Related]
38. Identification of Functional HLA-A*01:01-Restricted Epstein-Barr Latent Membrane Protein 2-Specific T-Cell Receptors.
Huisman W; Gille I; van der Maarel LE; Hageman L; Morton LT; de Jong RCM; Heemskerk MHM; Amsen D; Falkenburg JHF; Jedema I
J Infect Dis; 2022 Sep; 226(5):833-842. PubMed ID: 32808978
[TBL] [Abstract][Full Text] [Related]
39. Isolation and functional characterization of hepatitis B virus-specific T-cell receptors as new tools for experimental and clinical use.
Wisskirchen K; Metzger K; Schreiber S; Asen T; Weigand L; Dargel C; Witter K; Kieback E; Sprinzl MF; Uckert W; Schiemann M; Busch DH; Krackhardt AM; Protzer U
PLoS One; 2017; 12(8):e0182936. PubMed ID: 28792537
[TBL] [Abstract][Full Text] [Related]
40. Reprogramming T lymphocytes for melanoma adoptive immunotherapy by T-cell receptor gene transfer with lentiviral vectors.
Bobisse S; Rondina M; Merlo A; Tisato V; Mandruzzato S; Amendola M; Naldini L; Willemsen RA; Debets R; Zanovello P; Rosato A
Cancer Res; 2009 Dec; 69(24):9385-94. PubMed ID: 19996290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
